Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve un-audited financial results ....
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 13th February 2026, to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025, along with the Limited Review Reports of the Auditors. The trading window for designated persons is already closed from 1st January 2026 and will remain so until 48 hours after the results are published. This is a standard pre-results intimation under SEBI LODR Regulation 29 and does not contain any actual financial numbers or commentary.
No direct impact on the stock from this filing — it is a routine procedural announcement. Investors should watch 13th February 2026 for the actual Q3 FY26 numbers, which could move the stock depending on performance versus expectations.